Table 3 Inter-relationship of imaging response, MRD and serological response assessments.
From: Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma
A | ||||
|---|---|---|---|---|
Bone marrow MRD | Total | p value1 | ||
Negative | Positive | |||
Imaging response | 0.3 | |||
RAC1 | 24 (44%) | 13 (24%) | 37 (67%) | |
RAC2+ | 9 (16%) | 9 (16%) | 18 (33%) | |
Total | 33 (60%) | 22 (40%) | 55 (100%) | |
B | ||||
|---|---|---|---|---|
IMWG response | Total | p value1 | ||
sCR/CR | <CR | |||
Imaging response | 0.5 | |||
RAC1 | 25 (36%) | 22 (32%) | 47 (68%) | |
RAC2+ | 10 (14%) | 12 (17%) | 22 (32%) | |
Total | 35 (51%) | 34 (49%) | 69 (100%) | |
C | |||
|---|---|---|---|
Characteristic | HR1 | 95% CI1 | p value |
Imaging response | |||
RAC1 | — | — | |
RAC2+ | 2.08 | 1.01, 4.31 | 0.048 |
IMWG response | |||
CR | — | — | |
<CR | 2.00 | 0.98, 4.08 | 0.057 |
2 + HRCA | 1.43 | 0.89, 2.28 | 0.14 |